Rosetta Genomics Ltd. Income (Loss) from Continuing Operations, Per Diluted Share
Rosetta Genomics Ltd. reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.71 per share for the 6-month period ending 2013-06-30, per its 6-K filed 2013-09-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2013-09-09
- 2013-06-30: Income (Loss) from Continuing Operations, Per Diluted Share 6 month $0.71.
- 2012-06-30: Income (Loss) from Continuing Operations, Per Diluted Share 6 month $5.39.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 6 month |
|---|---|
| 2013-06-30 | $0.71 6-K · filed 2013-09-09 |
| 2012-06-30 | $5.39 6-K · filed 2013-09-09 |